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IMMUNIZATION WITH TETANUS TOXOID
THE RECALL RESPONSE*
HENRY B. STRENGE
Although immunization with tetanus toxoid cannot be expected
to produce an adequate permanent immunity, a number of investi-
gators have confirmed and extended the observation of Ramon3 to
the effect that an organism, once immunized, will respond to further
injections of toxoid with an accelerated and increased antitoxin pro-
duction. That this response to the "injection de rappel" does occur
has been adequately and clearly demonstrated, but it has not been
entirely proved that this recall response takes place rapidly enough
to provide effective protection against infection with tetanus. It was
the purpose of this investigation to add to the available information
on this point.
Materials and methods
The subjects of this investigation were 42 students of Yale University,
all in general good health, who had been immunized against tetanus, either
because they had a definite history of serum sickness or were known to be
allergic to other substances, and hence, presumably, to horse serum. The age
range was from 18 to 21 years. These subjects had received two 1 cc. doses
of commercial tetanus toxoid, alum precipitated (APT). The interval
between the two doses averaged 63 + 8 days. The recall injection was given
after 283 i 28 days. The variation in this interval is due to the fact that
primary immunization was done routinely rather than experimentally, and
hence occurred through the year. The procedure in these tests was essen-
tially as follows:
After a 10 cc. specimen of blood was removed for titration of residual
antitoxin, the subject was given a recall dose of 1 cc. APT intramuscularly.
Blood samples for antitoxin titration were again taken on the 5th and 10th
days after the recall injection. A 5-day interval was selected because Cowles'
has shown that most subjects then have their first significant rise in antitoxin.
The 10-day interval was selected as being the approximate time of maximum
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response. In 7 subjects a 4th sample was taken.330 days after the recall dose
in order to compare the residual antitoxin with that resulting from the primary
immunization.
For the titration of antitoxin in these sera, a solution of tetanus toxin
(10 mg. per cc. in 50 per cent glycerine) standardized against U.S.P.H.D.
antitoxin was used. That quantity of toxin was determined which killed a
white mouse of 20 to 30 gm. in 4 days after injection of a mixture of toxin
and 0.04 unit of antitoxin. In the actual titration, various dilutions of the
subjects' sera were made with physiological saline, mixed with the standard
quantity of toxin, allowed to stand 30 minutes, and injected into mice (vol-
ume 1 cc.). That dilution of serum which just failed to protect the mouse
against death from tetanus on the 4th day contained, therefore, 0.04 unit of
antitoxin and the antitoxin content of the undiluted serum was readily com-
puted. Dilutions of the serum were used which gave titration levels of 0.04,
0.1, 0.2, 0.5, 1, 2, 4, 8, 16, 25, and 50 units. For those sera which con-
tained less than 0.04 unit per cc., another standard quantity of toxin equiva-
lent to 0.01 unit of antitoxin was determined, and sera titrated at 0.01 and
0.02 units. No titrations were carried out below 0.01 unit. In those cases
where none of the mice died on the 4th day, but where one receiving a smaller
amount had died earlier, while the mouse receiving the next larger dose of
serum survived, an intermediate antitoxin value was assigned to the serum.
This interpolation was considered justifiable in view of the fact that Knerr
and Hottle2 have used variable survival times as the determining factor in
their method for estimation of small quantities of antitoxin in serum.
Results
Most of the subjects injected developed a local reaction, but
only one subject (case 14) experienced a general reaction. This
appeared some 8 hours after injection and consisted of general
malaise and some arthralgia, with a temperature of 101° F. In no
case was there urticaria or generalized lymphadenopathy. Of the
42 subjects studied, 4 were omitted from the average of residual
levels. Case 35 had received a single dose and had failed to com-
plete his immunization until 406 days later, when he was given two
1 cc. injections 61 days apart. Another, case 15, because of an injury
was given a recall dose 177 days after his primary immunization.
The levels of these two cases were higher than the general average,
although within the range, being 0.2 and 0.4 units per cc. respec-
tively. Two other cases, Nos. 30 and 40, were omitted because
they had residual levels far above the average range, i.e., 1.5 and 5.0
units respectively.
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The average residual level in the sera of the remaining 38 sub-
jects (283 days after the last dose of toxoid) was 0.11 4 0.07 unit
per cc. Of all cases, 52 per cent had serum levels of 0.1 unit or
more. Only one had less than 0.01 unit.
Response to the recall dose
The.average serum antitoxin level of the 38 cases (omitting the
4 previously mentioned) on the 5th day after the recall dose of
toxoid was 0.53 i 0.26 unit per cc. Three cases had less than 0.1
unit per cc. Case 41, who had had a residual level of 0.06 unit per
cc., had only 0.04 unit per cc. on the 5th day after recall, but on the
10th day he had a level of 6 units per cc. Case 36, with a residual
level of 0.02 unit, had only 0.015 unit 5 days after recall, but 3 units
per cc. on the 10th day. The third of these poor reactors had 0.08
unit per cc. before recall and only 0.06 unit per cc. 5 days after. No
blood sample could be obtained from this subject on the 10th day.
Of all cases titrated on the 5th day, 92 per cent had 0.1 unit or more
per cc. and 49 per cent had 0.5 or more unit per cc.
The average serum antitoxin level on the 10th day (excluding
case 40, which showed 25 units per cc.) was 4.3 i 2.1 units per cc.
All cases had more than 0.5 unit per cc.; 92 per cent, i.e., all but 2
of 37 cases, had 1 unit or more per cc., and 49 per cent had 4 units
or more per cc.
Seven of the cases mentioned were tested 330 days after the
recall dose, and the serum levels of these were 0.015, 0.06, 0.4, 0.5,
0.7, 1.5, and 1.5 units per cc.
Discussion
One must conclude from a review of the experimental work,
particularly that of Cowles' and of Sneath,4 that at least 0.1 unit
per cc. of antitoxin must be present in the serum of a subject before
he can be considered adequately protected against tetanus. One
must also consider the adequacy of the serum level in terms of time
as well as of quantity. While the series presented in this. paper
shows that the average level of antitoxin following primary
immunization was above 0.1 unit per cc., an initial immunization
with toxoid certainly could not be counted on to provide protection,
since 48 per cent of the subjects had less than this arbitrary mini-
mal level 9 months after initial immunization. Following the
recall dose, on the 5th day, 8 per cent of this series had less than the
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minimum of 0.1 unit per cc. All, however, had more than 0.01
unit per cc., and it can probably be assumed that the incubation of
an infection with tetanus would be sufficiently prolonged in this
small group of slow reactors for the further increase in antitoxin to
take place. That such a further increase of antitoxin can occur is
shown by the fact that on the 10th day following the recall dose,
all cases had more than 0.5 unit per cc., a level probably adequate
for all but overwhelming infections.
Direct proof of the adequacy of active immunization against
tetanus is still lacking, but should be forthcoming in the next few
years. Ramon3 has reported the immunization of a million persons
against tetanus, with no case of the disease as yet reported.
The many disadvantages inherent in the use of prophylactic
antitoxin, such as its transitory effectiveness and the discomforts and
dangers attendant upon the introduction of its usual vehicle, horse
serum, should encourage further study of the problems of active
immunization.
Conclusions
1. Of 42 individuals examined 9 months after primary immuni-
zation with alum-precipitated tetanus toxoid, 52 per cent had serum
antitoxin levels of more than 0.1 unit per cc.,-an average level of
0.11 i 0.07 unit per cc.
2. Five days after a recall dose of toxoid the antitoxin levels in
these subjects had risen to an average of 0.53 4t 0.26 unit per cc., 92
per cent having 0.1 or more unit per cc.
3. Ten days after the recall dose the average level was 4.5 i 2.1
units per cc., every subject having more than 0.5 unit per cc.
4. Ten months after the recall dose 7 cases had an average of
0.67 ± 0.48 unit percc., 5 ofthem having more than 0.1 unit per cc.
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